{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-043919","form_type":"8-K","ticker":"EVFM","cik":"0001618835","company_name":"Evofem Biosciences, Inc.","filed_at":"2026-09-23T20:05:21+00:00","discovered_at":"2026-09-23T20:06:00.271886+00:00","generated_at":"2026-09-23T20:06:09.673703+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Evofem signs manufacturing deal with Zhaoke for PHEXX, targets 40%+ cost cut","bullets":["Manufacturing agreement with Zhaoke (Hong Kong) and Zhaoke (Guangzhou) dated Sept 17, 2026.","Expected to reduce PHEXX unit costs by 40% or more after FDA approval, improving economics.","Plans sNDA submission to FDA in mid-2027 for PHEXX from the new facility.","Adds second supply source to boost flexibility and capacity for US and global growth."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-043919","json":"https://secwatch.observer/filing/0001493152-26-043919.json","markdown":"https://secwatch.observer/filing/0001493152-26-043919.md","text":"https://secwatch.observer/filing/0001493152-26-043919.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1618835/000149315226043919/0001493152-26-043919-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1618835/000149315226043919/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-23T20:06:09.673703+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}